US-based medical technology firm Elixir MD, in an exclusive partnership with High Tech Medical, has launched a new subsidiary in Australia and New Zealand.
Established in 1999, High Tech Medical is a provider of specialist aesthetic medical devices in Australia and New Zealand.
The company introduced advanced technologies that facilitate minimally invasive treatments, reduce patient risk, and enhance clinical outcomes.
The collaboration aims to introduce the Elixir MD device across these markets, focusing on enhancing surgical recovery through non-invasive innovations.
High-Tech Medical managing director Matt Moncrieff said: “High Tech Medical is proud to work exclusively with Elixir MD, Ewan and the entire team have demonstrated a clear commitment to innovation and to reshaping the perioperative care model in plastic surgery.
The Elixir MD device and its proprietary treatment protocols represent a new gold standard in post-surgical recovery by significantly reducing patient downtime and improving outcomes.”
Based in Irvine, California, Elixir MD is focused on providing non-invasive, perioperative innovations in plastic surgery.
Currently, the company operates in 18 markets, including its new subsidiary in Australia and New Zealand.
The FDA-approved Elixir MD technology is designed to support faster healing and improved outcomes for surgeons and patients globally.
Elixir MD CEO Ewan Mohammed said: “We’re proud to join forces with High Tech Medical, Australia and New Zealand’s leading medical technology partner, to bring the Elixir MD device to facial surgery patients across one of the world’s fastest-growing cosmetic markets.
“With more than 25 years of proven commitment to clinical excellence, High Tech Medical brings deep market insight and trusted relationships throughout the aesthetic medical community.
“Their long-standing success in introducing advanced technologies to Australians and New Zealanders makes them the ideal partner for Elixir MD, Inc.”
